(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today Vraniak served as Chief Financial Officer of Evaxion Biotech A/S, an AI enabled immuno-oncology company

July 2022 " G.CLIPS biotech is 2 years old today🎂. Looking forward for more 🎊 #team #grateful #biotech #work #birthdaycelebration" Read more at the source

February 2022 "Switzerland Today, InterAx Biotech is pleased to announce that Carola Weiss has joined

I developed G.CLIPS biotech's innovative technology as a synthesis of the different knowledge, experiences Before founding G.CLIPS biotech in June 2020. GPCR Ecosystem G.CLIPS Biotech on the web Website LinkedIn Thanks for listening to this podcast episode

the University in Graz in Austria, Maria worked several years at Novo Nordisk before joining InterAx Biotech Maria Waldhoer on the web LinkedIn InterAx Biotech Pubmed Dr.

Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the academic and biotech Personalised Therapeutics Technologies, Chief Scientific Advisor to Dimerix, and co-founder of RAGE Biotech